- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/16 - Hormones
Détention brevets de la classe C12N 15/16
Brevets de cette classe: 166
Historique des publications depuis 10 ans
|
12
|
10
|
4
|
7
|
7
|
12
|
10
|
6
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The General Hospital Corporation | 4659 |
3 |
| The Trustees of the University of Pennsylvania | 4283 |
3 |
| Florey Institute of Neuroscience and Mental Health | 45 |
3 |
| Universidade de Sao Paulo - USP | 109 |
3 |
| Merck Sharp & Dohme LLC | 3755 |
3 |
| Merck Sharp & Dohme Corp. | 2214 |
2 |
| The Regents of the University of Michigan | 4596 |
2 |
| ADViSYS, Inc. | 9 |
2 |
| Ambrx, Inc. | 192 |
2 |
| Amicus Therapeutics, Inc. | 356 |
2 |
| AspenBio Pharma, Inc. | 7 |
2 |
| Biochrom Pharma Inc. | 5 |
2 |
| Chugh, Sumant S. | 8 |
2 |
| The Governors of the University of Alberta | 886 |
2 |
| Hanmi Pharm. Co., Ltd. | 553 |
2 |
| Laboratoires Serono S.A. | 39 |
2 |
| National Cerebral and Cardiovascular Center | 146 |
2 |
| National Research Council of Canada | 1576 |
2 |
| Ouro Fino Saúde Animal Participações S.A. | 4 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4055 |
2 |
| Autres propriétaires | 121 |